No Data
No Data
Celi Healthcare: third quarter report 2024
Third Quarter Report 2024
Thalys Medical Technology Group Corporation (603716.SH) released its performance for the first three quarters, with a net loss of 56.0251 million yuan.
Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report for 2024, with a revenue of 14...
thalys medical technology group corporation (603716.SH): a net loss of 56.025 million yuan in the first three quarters.
October 28th, Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report, with revenue of 1.42 billion yuan, a year-on-year decrease of 7.15%, net loss of 56.025 million yuan, non-recurring net loss of 26.11 million yuan, and basic earnings per share of -0.28 yuan.
Thalys Medical Technology Group Corporation (603716.SH): has officially started the payment of liquidation funds and the related bonds cancellation work.
On October 15, GeLongHui reported that thalys medical technology group corporation (603716.SH) announced that the company needs to cancel part of the shares in the repurchased special securities account and correspondingly reduce the registered capital. Bondholders have the right to request the company to repay the debt or provide corresponding guarantees within forty-five days from the date of this announcement. As of June 14, 2024, the bond declaration registration period has expired. Some holders of "Thalys Convertible Bonds" have requested early repayment from the company, but no request for guarantees from bondholders has been received. The company had previously continuously disclosed the repayment work plan and progress related to the bond repayment matters. Currently, the corresponding fund raising and final registration matters have been in progress.
Thalys Medical Technology Group Corporation (603716.SH) plans to divest 80% equity of Hui Xin Technology, focusing on lean management services for medical consumables business.
Thalys Medical Technology Group Corporation (603716.SH) announced that the company is currently focusing on lean management services for medical consumables (SP...
No Data
No Data